Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP288 | DOI: 10.1530/endoabs.81.EP288

ECE2022 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (318 abstracts)

Surrogate measures of insulin secretion and sensitivity (IS) in young children with beta thalassemia major on repeated blood transfusion and iron chelation therapy.

Vincenzo De Sanctis 1 , Shahina Daar 2 , Ashraf Soliman 3 , Ploutarchos Tzoulis 4 , Mehran Karimi 5 & Christos Kattamis 6


1Quisisana Hospital, Pediatrics, Italy; 2College of Medicine, Sultan Qaboos University, Pediatrics, Muscat, Oman; 3Hamad Medical Center, Pediatrics, Doha, Qatar; 4Department of Diabetes and Endocrinology, Whittington Hospital, University College London, London, United Kingdom; 5Hematology Research Center, Shiraz University of Medical Sciences, Hematology, Shiraz, Iran; 6National Kapodistrian University of Athens, Greece, First Department of Paediatrics, Athens, Greece


We assessed glycemia and insulin markers in 18 young children with beta thalassemia major (BTM). Insulin markers measured included: the Homeostatic Model Assessment index of insulin resistance (HOMA-IR), Matsuda index (MI), the insulinogenic index (IGI), and the oral disposition index (oDI). 9 had normal fasting glucose (FG) and 9 had impaired fasting glucose (IFG)

Results: HOMA-IR, a marker of IR was significantly higher in children with BTM compared to normal controls. Fasting insulin was significantly higher in children with BTM patients vs normal children. Despite higher fasting insulin compared to controls thalassaemic children (group A) had higher fasting glucose levels. Both findings support an insulin resistance state early in these patients. oDI was significantly lower in children with BTM (with and without IFG) compared to normal controls.

Baseline variablesChildren with β -TM and NGT (n: 9)Group AChildren with β -TM and isolated IFG (n:9) Group BControls (n.9) Group CP-value A vs. BP-value A vs. CP-value B vs. C
Chronological age (yrs)5.41±0.725.59±1.735.14±0.4NSNSNS
Gender (Males/Females)4/56/35/4---
BMI (kg/m2)17.5±2.918.1±2.718.1±3.1NSNSNS
Serum ferritin (ng/ml)1,867±654.91,848±307.0-NS--
ALT (U/l)117.3±92.974.11±46.67-NS--
Fasting plasma glucose (mg/dl)84.7±7.3108.4±5.076.3±7.4< 0.001NS< 0.001
Plasma glucose 2-h after OGTT (mg/dl)105.6±13.6107.1±18.686.0±12.0NS< 0.05< 0.05
Fasting insulin (μ U/ml)8.88±1.9610.5±2.73.7±2.7NS< 0.001< 0.001
MATSUDA INDEX (MI 0-120)6.70±2.246.38±2.2817.11±6.7NS< 0.001< 0.001
HOMA-IR1.92±0.532.85±0.770.72±0.52< 0.05< 0.001< 0.001
Insulinogenic Index (IGI)0.53±0.290.74±0.680.75±0.16NSNSNS
Oral disposition Index (oDI)3.45±2.114.01±3.8212.92±5.11NS< 0.001< 0.001

Conclusion: These findings supported the presence of significant insulin resistance in children with BTM on repeated blood transfusion and iron chelation

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.